Preparation of cord blood for infusion: bedside thaw, dilute and wash, or somewhere in between



Similar documents
Cord Blood: that other stem cell source. Donna Wall, MD Director, Manitoba Blood and Marrow Transplant Program

Beyond Cell Dose: Selection of the Optimal Umbilical Cord Blood Unit. Karen Ballen, MD Massachusetts General Hospital June, 2012

Recommendations to Transplant Centres Performing Cord Blood Transplants. Why Choosing the Right Thaw Method Could Save a Patient s Life

Cord Blood: Thawing & Infusion Practical Methods

Processing & Utilization of Cord Blood for Transplant

Public Cord Blood Banking at the National Cord Blood Program (NCBP)

Selection of the Optimal Umbilical Cord Blood Unit

Pr Eliane Gluckman, MD, FRCP, Disclosure of Interest: Nothing to Disclose

Umbilical Cord Blood Transplantation

Preamble. 1. If it is necessary, are you willing to receive follow up questions to help clarify any answers to the survey questions?

Cord Blood for Cellular Therapy: A Snapshot of this Evolving Market Landscape

14.0 Stem Cell Laboratory Services

Umbilical cord blood (UCB) is increasingly

UMBILICAL CORD BLOOD TRANSPLANTATION: KFSH EXPERIENCE

Automated Cord Blood Processing:

CPT Codes for Bone Marrow Transplant January 2015 James L. Gajewski, MD

A simple and reliable procedure for cord blood banking, processing, and freezing: St Louis and Ohio Cord Blood Bank experiences

The donor search: the best donor or cord blood unit

Navelstrengbloed tegen kanker

The Power & Potential of Cord Blood

BioArchive Freezing Curve for Cord Blood

The Power & Potential of Cord Blood

Cord Blood Market Trends, circa 2014

AUTOMATION OF THE COLONY-FORMING CELL ASSAY FOR MEASURING HEMATOPOIETIC PROGENITORS IN CORD BLOOD

Pros and Cons of Stem Cell Sources and their availability in Africa. Dr Jaimendra Singh Inkosi Albert Luthuli Central Hospital Durban, South Africa

Guidance for Industry and FDA Staff

Narrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood

Comparability of Cord Blood Units

How To Safely Infuse Aupbsc

CORD BLOOD BANKING IN BRAZIL HOSPITAL ISRAELITA ALBERT EINSTEIN S EXPERIENCE

hematopoietic stem cells from cord blood: - costless but too expensive? Dr. Vincent Kindler Geneva Cord Blood Bank HUG vincent.kindler@hcuge.

A Cure for Sickle Cell Anemia and Thalassemia

The Impact of Maternal, Neonatal and Collections factors on the TNC count of an Umbilical Cord Blood Donation

Natasha Kekre, 1 Jennifer Philippe, 2 Ranjeeta Mallick, 3 Susan Smith, 2 and David Allan 1,2,4. 1. Introduction

Dr Saeed Al Amoudi. Consultant Hematologist King s college hospital Director of Regional Lab Jeddah

Proliferation/Potency Assays: Is there more to CD34 and CFU?

Fresh PBSC harvests, but not BM, show temperature-related loss of CD34 viability during storage and transport

An Introduction to Canada s National Public Cord Blood Bank

Umbilical Cord Blood Stem Cells Current Status & Future Potential

Bone Marrow, Peripheral Blood Stem Cells or Umbilical Cord Blood transplantation? Federica Giannotti, MD Eurocord-Hôpital Saint Louis, Paris

In contrast to the very high transplant-related

Economics of Cord Blood Banking. Michael Boo NMDP Be The Match September 11, 2015

Transmedcon Ahmedabad, Gujarat November 14-16, 2014

BioPreservation Today

Overview of OneMatch, including the OneMatch Public Cord Blood Bank

Umbilical Cord Blood: An Alternative Allogeneic Stem Cell Source for Transplantation

Cord Blood Transplant. E. Gluckman Eurocord ESH-EBMT training course Vienna 2014

Review. Cord blood as an alternative source of haemopoietic stem cells. J. Hows, A. Nicol, P. Denning-Kendall, C. Donaldson, M. Nieda & B.

11/10/2011. History of CBUs. 10-CBA providing access to unlicensed cord blood units. The FDA s involvement. The FDA s involvement, cont.

Canadian Blood Services National Public Cord Blood Bank

Graft Failure After HSCT

Bone Marrow Transplantation and Peripheral Blood Stem Cell Transplantation: Questions and Answers. Key Points

STEM CELL TRANSPLANTS

Summary Basis for Regulatory Action

Blood-Forming Stem Cell Transplants

HPC, Cord Blood Injectable Suspension for Intravenous Use Initial U.S. Approval: 2012

OneMatch National. Sue Smith, Executive Director, Stem Cells

Review Article A Review of Factors Influencing the Banking of Collected Umbilical Cord Blood Units

Cord Blood Transplant Past and Future. E. Gluckman Eurocord ISCT Paris 24/04/2014

Umbilical Cord Blood Banks and Banking

Equine Stem Cells. Sources, Processing, Expansion, Storage and Shipping

The Value of Cord Blood Stem Cells. Mona Shafey, MD, FRCPC Medical Grand Rounds October 25 th, 2011

HEMACORD (HPC, Cord Blood) Injectable Suspension for Intravenous Use Initial U.S. Approval: 2011

Determinants of Engraftment after Double-Unit Cord Blood Transplantation

Automated and Standardized Counting of CFU Assays for Cord Blood Banks

Stem Cell Background Paper

Product Complaint Form Instructions

Corporate Medical Policy Cord Blood as a Source of Stem Cells

CBS National Public Cord Blood Bank. Did you donate your cord blood?

Stephen J. Szilvassy, PhD Associate Director, Hematopoietic Products R&D STEMCELL Technologies Inc., Vancouver, Canada

HEMACORD (HPC, Cord Blood) Injectable Suspension for Intravenous Use Initial U.S. Approval: 2011

Selecting an appropriately matched donor for hematopoietic

CHAPTER 1 BACKGROUND AND CORD BLOOD BANK (CBB) ORGANIZATION

Public Umbilical Cord Blood Banking at Canadian Blood Services. David Allan, MD Medical Director, National Public Cord Blood Bank 6 May 2015

Pl I enary Tr T anslational Medicine April 30, 2015

Processing Cord Blood With the SynGenX System

Meta-Analysis of the AXP and Sepax Automated Cord Blood Processing Systems

Enumeration and Viability of Nucleated Cells from Bone Marrow, Cord Blood, and Mobilized Peripheral Blood

Kathie Viers-City of Hope Eric Presson- Baylor Health Care Systems Jennifer Christian-Markay Cancer Center

Stem Cell Transplantation In Patients with Fanconi Anemia

HEMACORD (hematopoietic progenitor cells, cord blood) Injectable Suspension for Intravenous Use Initial U.S. Approval: XXXX

SAVE A LIFE... BY GIVING LIFE!

Disclosures. I have no disclosures.

Milano Cord Blood Bank 18 year report on cord blood banking and transplant

cord blood saves lives...

Peripheral Blood Stem Cell (PBSC) Collections: Why, What, When. Objectives. Sources of Stem Cells

Jennifer G. Collins, RN Children s Hospital of Chicago

Improved Ex Vivo Expansion of Functional CD34 + Cells Using Stemline II Hematopoietic Stem Cell Expansion Medium

Hematopoietic Stem Cell Transplantation. Imad A. Tabbara, M.D. Professor of Medicine

ALBERTA BLOOD AND MARROW TRANSPLANT PROGRAM NEW GUIDELINES FOR THE IMMUNIZATION OF HEMATOPOIETIC STEM CELL TRANSPLANT(HSCT) RECIPIENTS JULY 11, 2013

Do you have anything to add? If so, I d love to hear from you! Jessica Robinson Conference Manager Life

Cryopreservation Hematopoietic Progenitor Cells

Trasplante de Células Madre Hemopoyéticas. Dos décadas de progreso

Bone Marrow, Peripheral Blood Stem Cells or Umbilical Cord Blood transplantation? E. Gluckman WBMT meeting Cape Town November 14-16, 2014

Cord Blood Stem Cell Transplantation

CD34 numeration through the French external quality control: Impact in the implementation of new technical chapters at the European Pharmacopoeia

Fetal Maternal Immunity and Antileukemia Activity in Cord Blood Transplant. Recipients

10 th Annual International Cord Blood Transplantation Symposium June 7-9, 2012 Preliminary Scientific Program. Thursday, June 7

Cord Blood Re-imagined The use of cord blood stem cells for clinical applications and medical innovations

Stem Cell Transplantation

Transcription:

Preparation of cord blood for infusion: bedside thaw, dilute and wash, or somewhere in between Donna Wall, MD Director, Manitoba Blood and Marrow Transplant Program ISCT 2012

Disclosures: none

The problem: Cord blood grafts contain 1/10 th the number of hematopoietic progenitors (TNC, CD34, CFU) compared to other HSPC sources and are all previously frozen. Progenitor cell loss at time of thaw must be minimized.

Impact on graft characteristics on engraftment Duke retrospective review of 435 primarily pediatric (median age: 5.3 years) patients receiving a single-unit unrelated UCBT after myeloablative conditioning from 2000 to 2008 Cumulative incidences of neutrophil and platelet engraftment were 76.9% and 55% respectively Page BBMT 2011

Precryopreservation graft characteristics on the probability of platelet engraftment. Page BBMT 2011

Post-thaw graft characteristics and the probability of platelet engraftment Page et al. BBMT 2011

Higher CFU dosing was the only precryopreservation graft characteristic predictive of neutrophil (P =.0024) and platelet engraftment (P =.0063). In the post-thaw model, CFU dose best predicted neutrophil and platelet engraftment (both P <.0001). Page et al. BBMT 2011 Yoo et al. BMT 2007

Objectives: To review the 3 main approaches to CBU thaw and compare transplant outcomes To highlight special issues in the red cell replete units and pediatrics

Historical perspective: In the early days products were frozen without red cell depletion in bags that had a high propensity to break That led to thawing in the laboratory with a wash stem to remove red cell lysate and DMSO. Product volumes were 150-200 ml

The Rubinstein method Rationale was that during the freeze process cells became dehydrated from the hyperosmolar DMSO solution. Thus by thawing with a hyperosmolar combination of albumin and dextran one allowed cells to equilibrate more gently improving survival. The osmotic damage inflicted by the severe solute concentration gradient, however, can be averted by a simple 2-fold dilution after thawing, providing almost total recovery of viable hematopoietic progenitor cells. Rubinstein PNAS 1995

Products evolved Red cell and plasma depletion product volume down to 25 ml with 5 ml of DMSO Improved cryopreservation bag integrity Smaller products, often with 2 compartments

Bedside Thaw Adult transplant centers looked at small product (small red cell lysate and DMSO content) and concern of cell loss with wash Greatest risk was poor or non- engraftment This looks like our autologous PBSC products Hahn et al. BMT, 2003 Chow et al. BBMT 2007 Stiff et al. Blood 2005

Alternate approach: Dilute only Simple dilution with albumin/dextran would support laboratory thaw and potential benefit of stabilization with hyperosmolar solution 2-5 fold dilution in laboratory with 25% albumin/40% dextran solution Stability of product for at least 8 hours facilitating remote lab thaw Barker et al, BBMT 2007

Thaw approach Pro Con Bedside thaw Dilute only Dilute and wash No lab issues Similar to practice for other frozen products Controlled thaw Theoretical advantage of hyperosmolar reequilibration Removal of 80% of DMSO and red cell lysate Manipulation of small product at bedside Immediate infusion necessary High load of DMSO and red cell/white cell lysate Larger volume of infusion Same load of red cells and DMSO Risk of cell loss with centrifugation (bag breaking, Cell aggregation with centrifugation

Comparison of the 3 thaw methods St. Louis Cord Blood Bank thawed 10 products in a 37 degree water bath and immediately split product into 3 groups: Thaw only 2 fold dilution with dextran-albumin 2 fold dilution with dextran-albumin followed by centrifugation at 400g for 20 min.

Viable CD34 recovery between thaw methods (n = 10 per group) Dilution Wash Thaw p< 0.01 Regan et al, Transfusion 2010

CFC mean percent recovery (n = 10 per group), Dilute/Wash Thaw P< 0.01 Regan et al, Transfusion 2010

Transplant outcomes of 401 cord blood units exported from St. Louis Cord Blood Bank between 2001-2007 All units were red cell and plasma depleted All used in single cord transplants

Patient characteristics Thaw N = 36 Dilute N = 163 Wash N = 202 P value Age (median) 18 6 7 <0.01 Weight (kg) 48 18 24 <0.01 TNC recovery 99% 78% 79% <0.01 TNC /kg 3.1 5.7 4.4 <0.01 Post thaw viability 95 88 73 <0.1 Regan et al, Transfusion 2010

No difference in time to neutrophil recovery Regan et al, Transfusion 2010

Infusional toxicity reported to the SLCBB (2001-2007) No serious adverse events reported

Cell processing laboratory The cell product is much smaller than the lab is used to working with. Important to practice thaws Minimize cell loss Contingency plan to handle broken bags Careful with testing sample volumes Validated thaw procedure for the variety of products being used. Requires early communication between transplant team and laboratory

Pediatric considerations: DMSO load: <1 gram DMSO/kg Red cell lysate: <1 ml of red cell lysate/kg Volume: although young children can handle volume better than older adults, in general want to keep volume <20 ml/kg.

The red cell replete unit The products are plasma depleted resulting in hematocrit in 80% range. At thaw there is a lot of red cell and neutrophil lysate Reports of cardiac and renal toxicity when high cell numbers infused (double cord, small recipient) 120 pediatric (0.1-14 y) transplants with 40% washed and 60% thaw only OS was 79% and DFS was 70 % at 3 years Petz et al. Transfusion on line 2011

Conclusions: For cord blood units that have been banked after red cell and volume reduction there are similar transplant outcomes with the 3 thaw approaches Special consideration is needed for pediatric recipients and red cell replete units Retrospective review of CIBMTR experience is ongoing (Ballen et al)

Acknowledgements: Donna Regan and Jonathan Woffard St. Louis Cord Blood Bank

Improved hematopoietic progenitor cell reservoir following cord blood vs. bone marrow transplant 2 groups of children: 12 CB recipients and 12 adult BM recipients Recipients of BM transplants received 10-fold more cells and had significantly faster neutrophil and platelet recovery At 1 year after transplantation, the frequency of colonyforming cells (CFCs) and long-term culture initiating cells (LTC-ICs) were compared Frassoni et al, Blood 102:1138

Comparison of marrow hematopoietic progenitors following CB vs BM transplant Cord Blood Recipients (n=12) Bone Marrow Recipients (n=12) CFC/2 x 10 4 BM mononuclear cells 20 11 P =.007 LTC-IC/10 6 BM mononuclear cells 8.2 0.2 P =.001

Public cord blood banking Despite heavy support by national bodies the cost of units is high $25-40,000/unit Chance of finding a donor increases if you collect from families of similar ethnic background Hema-Quebec is the largest public bank in Canada Smaller banks in Toronto and Edmonton